| Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304) |
|---|
| 01/31/2008 | US20080027211 Enantiopure Heterocyclic Compound Useful for the Preparation of Peptides Which Can Be Potentially Used as Medicaments |
| 01/31/2008 | US20080027127 Trans Pyrrolidinyl Derivates and Their Pharmaceutical Use |
| 01/31/2008 | US20080027126 Pyrrolidin-2-One Derivatives for Use as Dp1 Receptor Agonists |
| 01/31/2008 | US20080027109 bis-[2-(pivaloylamino)phenyl]disulfide; cholesteryl ester transfer protein (CETP); atherosclerosis, hyperlipidemia |
| 01/31/2008 | US20080027107 With nitrogen containing heterocyclic substituents; for example, 1-{[(2-dimethylamino)ethyl]amino}-4-{[2-(3-hydroxypiperidin-1-yl)ethyl]amino}-anthracene-9,10-dione |
| 01/31/2008 | US20080027093 Cyclohexylalanine Derivatives as Dipeptidyl Peptidase-IV Inhibitors for the Treatment or Prevention of Diabetes |
| 01/31/2008 | US20080027061 omega-Carboxy Aryl Substituted Diphenyl Ureas As p38 Kinase Inhibitors |
| 01/31/2008 | US20080027060 Dipeptide nitriles |
| 01/31/2008 | US20080027037 Cyclic compounds |
| 01/31/2008 | US20080027035 Dpp-Iv Inhibitors |
| 01/31/2008 | US20080026933 Cyclopentadiene rings substituted with dihydrocarbylphosphino- or cyclic phosphino- groups and amino- or oxy- methyl groups: bis[diphenylphosphino-methoxymethylpyrrolidinomethylcyclopentadienyl]iron; transition metal complexes; catalyzing asymmetric hydrogenation of double bonds in prochiral compounds |
| 01/31/2008 | US20080026310 Oxo-titanylphthalocyanine crystal, method for producing the same, and electrophotographic photoreceptor |
| 01/31/2008 | US20080025919 Benzoylguanidine salt and hydrates thereof |
| 01/31/2008 | CA2831219A1 Modulators of chemokine receptor activity, crystalline forms and process |
| 01/31/2008 | CA2659259A1 Modulators of chemokine receptor activity, crystalline forms and process |
| 01/31/2008 | CA2659253A1 Modulators of chemokine receptor activity, crystalline forms and process |
| 01/31/2008 | CA2658913A1 Substituted aniline derivatives |
| 01/31/2008 | CA2658558A1 Inhibitors of undecaprenyl pyrophosphate synthase |
| 01/31/2008 | CA2657571A1 Process for the preparation of levetiracetam |
| 01/30/2008 | EP1882686A2 Pyrrolidine and piperidine derivates as nk1 antagonists |
| 01/30/2008 | EP1882684A1 Pyrrolidine derivative or salt thereof |
| 01/30/2008 | EP1881975A1 N,n-substituted 3-aminopyrrolidine compounds useful as monoamines reuptake inhibitors |
| 01/30/2008 | CN101115745A Mitotic kinesin inhibitors |
| 01/30/2008 | CN101115716A Substituted pyrroles, compositions containing same, method for making same and use thereof |
| 01/30/2008 | CN101115715A Pyrrolidine derivatives for the treatment of a disease depending on the activity of renin |
| 01/30/2008 | CN101115481A Phenyl-substituted pyrrolidones |
| 01/30/2008 | CN101113146A Process for the separation of blood fat recovery purpose-made monascus active ingredient |
| 01/30/2008 | CN100364971C Pyrrolidine-2-ones as factor Xa inhibitors |
| 01/29/2008 | US7323608 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
| 01/29/2008 | US7323571 Heterodimeric dye composition |
| 01/29/2008 | US7323495 Synthetic lactone formulations and method of use |
| 01/29/2008 | US7323492 7-pyrollyl 9-aminoacyl tetracycline compounds and methods of use thereof |
| 01/29/2008 | US7323491 Heterocyclic compounds, their preparation, pharmaceutical compositions containing them and their use in medicine |
| 01/29/2008 | US7323490 Pyrrole compounds and uses thereof |
| 01/29/2008 | US7323489 As prodrug of enalaprilat, which is a medicine useful for preventing or treating circulatory diseases such as hypertension, cardiac diseases, nephritis, and apoplexy, patches; 1-[N-[(1S)-1-Carboxy-3-phenylpropyl]-L-alanyl]-L-proline 2-hydroxyethyl ester |
| 01/29/2008 | US7323448 Antibacterial agents |
| 01/29/2008 | US7323447 Hepatitis C virus inhibitors |
| 01/29/2008 | US7323286 Exposure latitude and line-edge roughness |
| 01/29/2008 | CA2383298C New amino acids, their preparation process and pharmaceutical compositions that contain these amino acids |
| 01/29/2008 | CA2255620C Novel anandamide amidase inhibitors as analgesic agents |
| 01/29/2008 | CA2220999C Process for the hydrogenation of imines |
| 01/24/2008 | WO2008011539A2 Anesthetic compounds |
| 01/24/2008 | WO2008011392A2 Proline urea ccr1 antagonists for the treatment of autoimmune diseases or inflammation |
| 01/24/2008 | WO2007136668A3 N-benzoyl-and n-benzylpyrrolidin-3-ylamines as histamine-3 antagonists |
| 01/24/2008 | WO2007133597A9 Crystalline form of atorvastatin calcium stable after storage |
| 01/24/2008 | WO2007109152A3 Amine/amide-functionalized lipophiles |
| 01/24/2008 | WO2007103719A3 MODULATORS OF 11-β HYDROXYL STEROID DEHYDROGENASE TYPE 1, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USING THE SAME |
| 01/24/2008 | US20080021225 Process for the synthesis of peptides containing a 4-hydroxy-proline substructure |
| 01/24/2008 | US20080021223 Colorant-Containing Curable Composition, Color Filter Using The Composition, and Method For Manufacturing The Same |
| 01/24/2008 | US20080021081 e.g. 4'-2-{[(2S)-2-methylpyrrolidin-1-yl]methyl}cyclopropyl)-1,1'-biphenyl-4-carbonitrile; histamine-3 receptor ligand; neuroleptic agent, neurodegenerative diseases, cognition activator; attention-deficit hyperactivity disorder, schizophrenia, Alzheimer's disease, epilepsy, seizures, allergic rhinitis |
| 01/24/2008 | US20080021065 Novel benzamidine compound |
| 01/24/2008 | US20080021054 Compositions and treatments for inhibiting kinase and/or hmg-coa reductase |
| 01/24/2008 | US20080021043 Piperidines and Related Compounds for Treatment of Alzheimer's Disease |
| 01/24/2008 | US20080021005 Pegylated Ion Channel Modulating Compounds |
| 01/24/2008 | DE60128472T2 Kombinierte tumortherapie auf der basis von distamycin-acryloylderivaten und alkylierungsmitteln Combined tumor therapy on the basis of distamycin acryloylderivaten and alkylating agents |
| 01/24/2008 | CA2658096A1 Selective androgen receptor modulators, analogs and derivatives thereof and uses thereof |
| 01/24/2008 | CA2656510A1 Anesthetic compounds |
| 01/23/2008 | EP1880720A1 Substituted acrylamide derivative and pharmaceutical composition comprising the same |
| 01/23/2008 | EP1879895A1 Enzyme inhibitors |
| 01/23/2008 | EP1879863A1 Amide resorcinol compounds |
| 01/23/2008 | EP1879862A2 Magnesium salts of hmg-coa reductase inhibitors |
| 01/23/2008 | EP1879861A2 Process for preparing levetiracetam and racemization of (r)- and (s)-2-amino butynamide and the corresponding acid derivatives |
| 01/23/2008 | EP1667635A4 Sulfonylaminovalerolactams and derivatives thereof as factor xa inhibitors |
| 01/23/2008 | EP1272178B1 Bilirubin or biliverdin degradation fragments |
| 01/23/2008 | EP1257547B1 1,3-disubstituted pyrrolidines as alpha-2-adrenoceptor antagonists |
| 01/23/2008 | EP1196404B1 Piperazine derivatives as modulators of chemokine receptor activity |
| 01/23/2008 | CN101111493A 3-alkyl-5- (4-alkyl-5-oxo-tetrahydrofutran-2-yl) pyrrolidin-2-one derivatives as intermediates in the synthesis of renin inhibitors |
| 01/23/2008 | CN101111462A Process for production of fluoro derivative |
| 01/23/2008 | CN101111246A Synthesis of aryl pyrrolidones |
| 01/23/2008 | CN101108809A 1- (alkylaminoalkyl-pyrolidin-/piperidinyl) -2, 2-diphenylacetamide derivatives as muscarinic receptor antagonists |
| 01/23/2008 | CN100363346C Small molecular inhibiting agent for coronavirus main proteinase, its preparation method and uses |
| 01/22/2008 | US7321063 Sulfonamide inhibitors of aspartyl protease |
| 01/22/2008 | US7320997 Pharmaceutical compositions including carotenoid ester analogs or derivatives for the inhibition and amelioration of disease |
| 01/22/2008 | CA2420999C 2-substituted heterocyclic compounds and their use in treating multidrug resistance |
| 01/22/2008 | CA2312431C New compounds |
| 01/17/2008 | WO2008007169A1 An enantioselective synthesis of pyrrolidine-substituted flavones |
| 01/17/2008 | WO2008006702A1 11beta-hydroxysteroid dehydrogenase type 1 active compounds |
| 01/17/2008 | WO2008006626A1 Triphenyl modified 5-membered heterocycles and their use as anticancer and antiinflammatory agents |
| 01/17/2008 | WO2007130616A3 Polyamides for treating human papilloma virus |
| 01/17/2008 | WO2007016476A3 Hepatitis c serine protease inhibitors and uses therefor |
| 01/17/2008 | US20080015351 Fluoroboron compound, aminomethylating agent for aromatic ring made of the same, and production method of compound containing aminomethyl aromatic ring using aminomethylating agent |
| 01/17/2008 | US20080015246 Novel ligands that modulate RAR receptors and pharmaceutical/cosmetic compositions comprised thereof |
| 01/17/2008 | US20080015245 1,5-diarylpyrrole derivatives, preparation method thereof and application of same in therapeutics |
| 01/17/2008 | US20080015239 For glaucoma or ocular hypertension, irritable bowel disease, and maintenance of colonic mucous |
| 01/17/2008 | US20080015192 Inhibitors of polo-like kinases |
| 01/17/2008 | US20080015180 Methods and compositions for treating amyloid-related diseases |
| 01/17/2008 | US20080015169 Amino-methyl substituted tetracycline compounds |
| 01/17/2008 | US20080015146 e.g. 3-Amino-1-[(S)-2-(3-tert-butyl-[1,2,4]oxadiazol-5-yl)-pyrrolidin-1-yl]-4-(2,4,5-trifluorophenyl)-butan-1-one; dipeptidyl-peptidase inhibitor; antidiabetic, hypoglycemic agent; metabolic disorders, obesity, non-insulin dependent diabetes |
| 01/17/2008 | US20080014207 Inhibitors of apoptosis proteins (IAP); antiproliferative agents; anticancer agents |
| 01/17/2008 | US20080014173 N-(4,6-dimethyl-2-pyridinyl)-L-valyl- N-(1-((cyclopropylsulfonyl)carbamoyl)-2-vinylcyclopropyl)-4-((6-methoxy-1-isoquinolinyl)carboxy)-L-prolinamide; viricide; synergistic with other active ingredients |
| 01/17/2008 | CA2658215A1 An enantioselective synthesis of pyrrolidines-substituted flavones |
| 01/17/2008 | CA2657078A1 11beta-hydroxysteroid dehydrogenase type 1 active compounds |
| 01/16/2008 | EP1878734A1 Novel lactam compound |
| 01/16/2008 | EP1877404A2 Novel cyclic amines |
| 01/16/2008 | EP1877393A2 Processes for preparing darifenacin hydrobromide |
| 01/16/2008 | EP1877375A1 Process for preparing a crystalline form of atorvastatin hemi-calcium |
| 01/16/2008 | EP1877374A1 Organic nitric oxide enhancing salts of angiotensin converting enzyme inhibitors, compositions and methods of use |
| 01/16/2008 | EP1755593B1 Naphthalene derivatives useful as histamine-3-receptor ligands |
| 01/16/2008 | EP1687288B1 Substituted aryl cycloalkanol derivatives and methods of their use |
| 01/16/2008 | EP1644320B1 Indane derivates as muscarinic receptor agonists |